Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Quanscient | $5,667,883 | (Nov 5, 2024)
Matter Bioworks
United States
- New York
- 24/10/2023
- Unknown
- Undisclosed Amount
Matter Bioworks is a longevity holding company focused on preserving genome integrity
As we age, our genome is constantly being damaged by exogenous and endogenous sources.
Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss.
At Matter, we have assembled a world-class team of scientists and executives to help counter this critical information loss in the genome.
To achieve this, we are focusing on a number of assets that address key stages in the genomic information loss continuum.
- Industry Biotechnology Research
- Website http://www.matterbio.com/
- LinkedIn https://www.linkedin.com/company/matter-bioworks/about/
Related People
Christopher BradleyCo Founder
United States -
New York, New York
I am a serial entrepreneur with a background in both biology and technology, and love to combine those two passions to innovate at the bleeding edge of biotech.
My current mission is to increase healthy human longevity. To achieve this, I'm working on two related problems:
1) Treating advanced cancer when it already exists
2) Preserving DNA information integrity to prevent disease from emerging to begin with.
I'm always interested in connecting with fellow scientists, entrepreneurs , investors and anyone else passionate about breakthrough science + tech, so if this sounds like you please feel free to reach out!
Miros | $6,535,520 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Further | $4,100,000 | (Nov 5, 2024)
Plato | $6,500,000 | (Nov 5, 2024)
cloudsquid | $1,000,000 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
Birl | $647,878 | (Nov 5, 2024)
Inquis Medical, Inc. | $40,000,000 | (Nov 5, 2024)
CrossBridge Bio | $10,000,000 | (Nov 5, 2024)